intellectual property rights
The TRIPS waiver on Covid-19 pharmaceuticals and the Big Pharma
June 2, 2021
There is a raging debate about whether or not the WTO should temporarily waive some intellectual property rights of Covid-19 pharmaceuticals. Developed countries oppose the proposal, but recently the US has announced its limited support, while the EU continues to wrangle over its necessity. For proponents, the waiver would speed up and scale up vaccine production and contribute to a faster vaccination process in poorer countries.
RCEP: Giving Up Sovereignty and Development
September 4, 2017
IBON Foundation Statement for the Regional Comprehensive Economic Partnership (RCEP) Stakeholder Consultation Interface with DTI and Key Agencies Manila, September 4, 2017 IBON welcomes this opportunity to interact with the DTI and key agencies on their negotiations for the Philippines on the RCEP. We look forward to hearing from our country’s negotiators. We also continue to […]
RCEP talks secretive, undemocratic – IBON
September 4, 2017
Research group IBON expressed concern about the secretive and undemocratic proceedings of the Regional Comprehensive Economic Partnership (RCEP) especially considering its apparent significant impact on the country’s economy, economic sovereignty and people’s welfare. The group said that it is the Duterte administration’s responsibility to ensure genuine transparency and public consultation to uphold the interests of […]
